Top Vaccines companies in France by EBITDA Margin

This ranking features the top 17 Vaccines companies in France ranked by EBITDA Margin, averaging a EBITDA Margin of -271.04%, for February 07, 2025.
#
Name
EBITDA Margin
Reported Date
Stock Price
Change
Price (30 days) Country
1
31.68%
Dec. 31, 2023 USD 3.46 -1.94%

France

2
26.06%
Dec. 31, 2023 USD 107.71 -0.06%

France

3
21.22%
Dec. 31, 2023 USD 76.53 1.34%

France

4
18.79%
Dec. 31, 2023 USD 26.53 0.03%

France

5
-14.60%
Dec. 31, 2023 USD 2.09 3.97%

France

6
-37.55%
Dec. 31, 2023 USD 3.46 7.58%

France

7
-50.59%
Dec. 31, 2023 USD 2.39 -7.42%

France

8
-100.09%
Dec. 31, 2023 USD 3.58 3.12%

France

9
-135.45%
Dec. 31, 2023 USD 1.42 2.06%

France

10
-155.83%
March 31, 2024 USD 17.01 1.06%

France

11
-157.55%
Dec. 31, 2023 USD 0.63 -3.60%

France

12
-556.11%
Dec. 31, 2023 USD 4.22 -0.94%

France

13
-583.86%
Dec. 31, 2023 USD 2.40 -1.45%

France

14
-785.86%
Dec. 31, 2023 USD 6.79 2.49%

France

15
-900.14%
Dec. 31, 2023 USD 5.82 3.14%

France

16
-956.80%
Dec. 31, 2023 USD 1.64 -0.17%

France

17
-2,882.64%
Dec. 31, 2023 USD 6.04 2.29%

France

Frequently Asked Questions
  • Which Vaccines company in France has the highest EBITDA Margin ?

    The Vaccines company in France with the highest EBITDA Margin is genOway SA (Paris Stock Exchange: ALGEN.PA) at 31.68%.

  • Which Vaccines company in France has the lowest EBITDA Margin ?

    The Vaccines company in France with the lowest EBITDA Margin is ABIVAX SA (Paris Stock Exchange: ABVX.PA) at -2,882.64%.

SV Wall Street